The CK CPK Isoenzyme Electrophoresis Test is a specialized diagnostic procedure aimed at analyzing the specific isoenzymes of Creatine Kinase (CK) or Creatine Phosphokinase (CPK) present in the blood. This test is particularly significant in identifying and evaluating various muscle and heart conditions, as CK/CPK enzymes are released into the bloodstream following muscle or heart tissue damage. By distinguishing between the different isoenzymes, healthcare providers can pinpoint the source of muscle damage, whether it be cardiac, skeletal, or due to other causes, facilitating accurate diagnosis and tailored treatment plans.
Performed at DNA Labs UAE, a state-of-the-art facility known for its advanced diagnostic services, the CK CPK Isoenzyme Electrophoresis Test is available for a cost of 1870 AED. The lab ensures precise and reliable results, utilizing the latest in electrophoresis technology to separate and identify the specific isoenzymes of CK/CPK. This test is instrumental for patients experiencing symptoms of muscle weakness, pain, or those who have suffered a heart attack, as it aids in assessing the extent of muscle damage and monitoring recovery. With its commitment to quality healthcare and diagnostic excellence, DNA Labs UAE provides a crucial service in the management of conditions affecting the heart and muscles.
The "FISH - RET Gene 10q11.2 Rearrangement Test" is a specialized diagnostic tool used to detect rearrangements in the RET gene located on chromosome 10q11.2. This test is particularly important in the study and management of certain types of cancers, including medullary thyroid carcinoma and other tumors associated with the RET proto-oncogene. The test employs Fluorescence In Situ Hybridization (FISH) technology, which allows for the visualization of specific genetic material in the cells. This technique can identify chromosomal abnormalities, including translocations and inversions, that might not be detectable with other testing methods. Conducted at DNA Labs UAE, a leading facility in genetic testing, the test is priced at 1870 AED. This facility ensures precise and reliable results, providing essential information for the diagnosis, prognosis, and treatment planning for patients with conditions related to RET gene rearrangements.
The Growth Disorder Panel Test, available at DNA Labs UAE for a cost of 1870 AED, is a comprehensive diagnostic tool designed to identify genetic factors contributing to various growth disorders. This specialized test examines a range of genetic markers associated with conditions that affect growth patterns, such as dwarfism, gigantism, and other growth hormone irregularities. By analyzing specific DNA sequences, the panel helps in pinpointing genetic mutations or abnormalities that may be influencing an individual's growth development. The results from this test can provide crucial insights for healthcare providers, enabling them to devise personalized treatment plans or interventions to address these growth disorders effectively. DNA Labs UAE, with its state-of-the-art facilities and expert team, ensures precise and reliable testing outcomes, making it a preferred choice for individuals seeking answers to growth-related concerns.
The HLA Mixed Antibody Screen - PRA (Panel Reactive Antibody) Class I, II, and MICA Test is a sophisticated diagnostic assessment designed to evaluate the presence of antibodies against human leukocyte antigens (HLA) and Major Histocompatibility Complex class I chain-related gene A (MICA) in the bloodstream. This test is crucial for individuals undergoing or planning to undergo organ transplantation, as the presence of these antibodies can significantly affect the compatibility between donor and recipient, potentially leading to transplant rejection.
The test specifically screens for antibodies against HLA Class I and Class II antigens, which are critical for immune response and organ transplant compatibility. Additionally, it assesses antibodies against MICA, which have been associated with transplant rejection and reduced graft survival. By identifying these antibodies, healthcare providers can better match donors and recipients, minimize the risk of rejection, and improve transplant outcomes.
Performed at DNA Labs UAE, a leading diagnostic and research facility, the test is executed with precision and accuracy, ensuring reliable results for patients and healthcare professionals. The cost of the HLA Mixed Antibody Screen - PRA Class I, II, and MICA Test is 1870 AED, reflecting the comprehensive and detailed analysis involved in this assessment.
This test represents a critical step in pre-transplant evaluation, helping to ensure the highest levels of compatibility and success in organ transplantation procedures.
Immunofixation Electrophoresis (IFE) 24 Hour Urine Test is a specialized laboratory test performed to detect and identify monoclonal immunoglobulins or M proteins in urine. This test is crucial in diagnosing and monitoring various disorders, particularly multiple myeloma and other related diseases that affect plasma cells. By analyzing a 24-hour urine sample, the IFE test provides detailed information about the presence of abnormal proteins, which are produced in excess in certain conditions. The test involves separating proteins based on their charge and size, followed by specific immunological identification, offering a highly sensitive approach to detect monoclonal gammopathies.
At DNA Labs UAE, the Immunofixation Electrophoresis (IFE) 24 Hour Urine Test is available for a cost of 1870 AED. This state-of-the-art facility ensures accurate and reliable results, employing advanced techniques and equipment under the supervision of experienced professionals. The test is recommended for individuals showing symptoms or with a medical history suggesting plasma cell disorders. It plays a vital role in the diagnostic process, helping healthcare providers to establish a precise diagnosis and tailor the most effective treatment plan for their patients.
The Immunohistochemistry Comprehensive Panel Test, available at DNA Labs UAE for a cost of 1870 AED, is a sophisticated diagnostic tool used in the field of pathology to detect and identify specific proteins within tissue samples. This test utilizes antibodies that are chemically linked to a dye to selectively bind to these proteins, allowing for the visualization of the distribution and localization of specific cellular components within cells and tissues. It serves a critical role in diagnosing various diseases, including different types of cancer, by identifying the presence or absence of tumor markers. The comprehensive nature of the panel ensures a broad spectrum analysis, making it a valuable asset in personalized medicine for determining the most effective treatment plans for patients. The test is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring high-quality and reliable results.
The Multiple Myeloma Screening Panel Test is a comprehensive diagnostic tool designed to detect and evaluate the presence of multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. This advanced screening test is crucial for identifying specific markers and abnormalities associated with multiple myeloma, including monoclonal protein levels, light chains in the blood, and other relevant indicators that help in diagnosing the condition accurately.
Performed at DNA Labs UAE, a leading facility known for its state-of-the-art technology and expertise in genetic and specialized testing, the Multiple Myeloma Screening Panel Test offers a thorough assessment for individuals at risk or presenting symptoms of this disease. The test cost is set at 1870 AED, reflecting the comprehensive nature of the screening and the detailed insights it provides into the patient's health status concerning multiple myeloma.
By opting for this screening panel, patients and healthcare providers can gain valuable information that aids in early detection, appropriate treatment planning, and monitoring the progression or remission of the disease. DNA Labs UAE ensures confidentiality, accuracy, and timely results, making it a trusted choice for this essential health screening.
The Myotonic Dystrophy Comprehensive Profile Test is a specialized diagnostic evaluation offered by DNA Labs UAE, designed to identify the genetic markers associated with Myotonic Dystrophy, a form of muscular dystrophy that affects muscle function and other body systems. This test plays a critical role in diagnosing the condition, enabling healthcare providers to tailor treatment plans and offer genetic counseling based on the results. Priced at 1870 AED, the test involves analyzing specific DNA sequences to detect mutations in the DMPK gene for Myotonic Dystrophy Type 1 or the CNBP gene for Type 2, which are the primary genetic contributors to the disorder. Conducted in the advanced facilities of DNA Labs UAE, this comprehensive profile provides valuable insights for patients and their families, guiding management and care decisions for those affected by Myotonic Dystrophy.
The Nicotine and Cotinine Urine Test is a specialized diagnostic procedure designed to detect the presence of nicotine and cotinine in the urine. Nicotine is a potent chemical found primarily in tobacco products, while cotinine is a metabolite of nicotine, indicating the body's processing of the substance. This test is particularly useful for assessing tobacco use or exposure to nicotine, and it can also be instrumental in monitoring individuals' smoking cessation progress.
Administered at DNA Labs UAE, a reputable laboratory known for its comprehensive range of diagnostic services, the test ensures accuracy and reliability in results. The process involves the collection of a urine sample, which is then analyzed for the levels of nicotine and cotinine, providing insights into the individual's nicotine consumption or exposure.
The cost of the Nicotine and Cotinine Urine Test at DNA Labs UAE is set at 1870 AED. This price reflects the sophisticated technology and expertise required to accurately detect and measure the substances in question. Individuals seeking to undergo this test can expect professionalism and confidentiality from the lab's staff, ensuring a smooth and informative testing experience.
Spino-Bulbar Muscular Atrophy (SBMA), also known as Kennedy's disease, is a rare, genetic motor neuron disorder characterized by muscle weakness and atrophy, primarily affecting males. The condition results from mutations in the androgen receptor gene, leading to progressive degeneration of motor neurons in the spinal cord and brainstem. Early symptoms often include tremors, muscle cramps, and difficulties with speech and swallowing.
The Spino-Bulbar Muscular Atrophy Test is a crucial diagnostic tool designed to confirm the presence of genetic mutations associated with SBMA. This test involves analyzing the patient's DNA to detect specific alterations in the androgen receptor gene that are indicative of the disease. Early and accurate diagnosis through genetic testing can aid in the management of symptoms, although there is currently no cure for SBMA.
In the UAE, DNA Labs offers the Spino-Bulbar Muscular Atrophy Test, ensuring that individuals suspected of having this condition can access reliable and precise genetic testing services. The cost of the test is 1870 AED, reflecting the specialized nature of the analysis and the expertise required to interpret the results. By opting for this test at DNA Labs UAE, patients and their families can gain valuable insights into their genetic status, enabling informed decisions about treatment options and lifestyle adjustments to better manage the condition's progression.
